Lecture 48/49 - Lymphomas and Myelomas Flashcards
what is a luekemia vs lymphoma vs myeloma? where do they abnormalities present
L eukemia vs Lymphoma vs Myleoma
○ Leukemia – abnormal proliferation of immature lymphoid/myeloid cells (blasts; ALL)
§ Bone marrow
○ Lymphoma -- Mature B cells growing out of control § Lymph Nodes ○ Myeloma -- plasma cell growing out of control § Bone marrow
what are the layers of a normal reactive LN from inner to outer?
Follicle
Mantle Zone
Marginal Zone
Describe the Ann Arbor Tumor staging for Lymphomas
Stage 1 – Single Location
Stage 2 – Multiple sites; same side of the diaphragm
Stage 1,2 – Localized disease; consider radiation therapy
Stage 3 – both sides of the diaphragm
Stage 4 – diffuse involvement of non lymphoid organs
Wide spread
Consider chemotherapy
Hodgkin Lymphoma –
what is it?
Localized single group of Nodes; contiguous spread
Extra nodal involvement is rare
Better Prognosis than Non-Hodgkin Lymphoma
Strongly associated with EBV
What is the classical morphology associated with Hodgkin Lymphoma
Reed Sternberg Cells
+Reactive benign Infiltrate
What are the 4 classical subtypes of Hodgkin Lymphoma?
What is the immunophenotype in general?
which are associated with EBV
CD15, 30+) and are EBV associated but to varying degrees
Nodular sclerosing (most common) Rare EBV association
Lymphocyte-rich
(do not confuse with lymphocyte-predominant)
40% EBV+
Mixed cellularity
70% EBV+
Lymphocyte depleted
90% EBV+
Immunophenotype of nonclassical HL subtype
CD15, CD30 and EBV Negative
Common Presentation + symptoms of HL
Enlarged LN in the neck, mediastinum, axilla
○ Often positive for EBV
○ 40% have B symptoms: night sweats, fevers, weight loss;
○ Itch
Sensitivity to alcohol
Treatment of HL:
(ABVD) +/- radiation therapy
□ Adriamycin (Doxorubicin), Bleomycin, Vinblastine, Dacarbazine
Outcomes/prognosis of HL
○ Limited stage – 85% disease free 10 years later
○ Wide spread - 70% disease free 10 years later
What are the NHL - B Cell Lymphomas?
Which are aggressive(more treatable)?
Which are indolent (less treatable)?
CLL/SLL
Diffuse Large B Cell Lymphoma — aggressive
Burkitts Lymphoma —- (some are EBV ASSOCIATED) — aggressive
Follicular Lymphoma – indolent
Marginal Zone – indolent
(H. Pylori associated)
NHL B Cell: DLBCL: - what is it/presentation - what are the causes? - - -
- Fast growing, large Bcell tumor mass; Disease may extend beyond LNs
Causes not well understood. Very Heterogeneous Origins
- what are the virally associated subtypes of DLBCL?
- what is are some possible genetic makers (translocation?
Immunodeficiency associated LBCL (eg such as with acquired immunodef or HIV)
Primary Effusion Lymphoma
HHV8 (Kaposis’ Sarcoma) Associated
Potential translocations: BCL6
t(14:18)
Treatment of DLBCL
+ what drug is used for CNS prophylaxis
treatment: RCHOP
Rituximab (anti CD20); Cyclophosphamide, Doxorubicin, Vincristine, Prednisone +/- Radiation
CNS prophylaxis: Methotrexate
NHL B Cell: Burkitt’s Lymphoma
- what is it/presentation?
an aggressive B cell tumor: extremely fast growing. Medical emergency